Trump Faces Pressure From US Industry Over China Tariff on Medicines
(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new tariffs on Chinese imports, as they join big pharma lobbyists who have said such trade barriers will cause shortages of medicines and higher prices in the United States.
Newell Brands' CEO said on Friday it is aiming to reduce its reliance on Chinese suppliers to minimize the impact of U.S.
US President Donald Trump signed an executive order on Friday delaying tariffs on lower-value packages from China that enjoy ...
As part of a 10% tariff on Chinese imports, Trump also scrapped a rule that waived import duties on packages valued at under ...
22h
Canadian Prime Minister Justin Trudeau announced that Canada would respond with 25% tariffs "against $155 billion worth of ...
Volkswagen's SEAT, the Spanish subsidiary of Europe's largest carmaker, will be forced to cut output and lay off around 1,500 ...
Asian equities rebounded, and tariff talk became more bark than bite for Canada and Mexico as the U.S. dollar fell.
The world's two biggest economies are on the brink of an economically destructive trade war. Here's what experts think could ...
China is the world's top energy importer but its purchases from the United States are relatively modest, blunting the impact ...
13hon MSN
President Donald Trump on Friday reversed his decision to eliminate the “de minimis” loophole that allowed packages from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback